Martingale Asset Management’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-21,166
| Closed | -$107K | – | 857 |
|
|
2022
Q4 | $107K | Buy |
21,166
+2,730
| +15% | +$13.8K | ﹤0.01% | 817 |
|
|
2022
Q3 | $92K | Buy |
18,436
+5
| +0% | +$25 | ﹤0.01% | 808 |
|
|
2022
Q2 | $69K | Buy |
18,431
+6
| +0% | +$22 | ﹤0.01% | 832 |
|
|
2022
Q1 | $104K | Buy |
+18,425
| New | +$104K | ﹤0.01% | 793 |
|
|
2017
Q2 | – | Sell |
-14,400
| Closed | -$52K | – | 969 |
|
|
2017
Q1 | $52K | Sell |
14,400
-4,900
| -25% | -$17.7K | ﹤0.01% | 930 |
|
|
2016
Q4 | $111K | Hold |
19,300
| – | – | ﹤0.01% | 951 |
|
|
2016
Q3 | $151K | Buy |
+19,300
| New | +$151K | ﹤0.01% | 934 |
|